Advertisement

BMC Musculoskeletal Disorders

, 20:505 | Cite as

Pain neuroscience education and physical exercise for patients with chronic spinal pain in primary healthcare: a randomised trial protocol

  • Miguel A. Galán-Martín
  • Federico Montero-Cuadrado
  • Enrique Lluch-Girbes
  • M. Carmen Coca-López
  • Agustín Mayo-Iscar
  • Antonio Cuesta-VargasEmail author
Open Access
Study protocol
Part of the following topical collections:
  1. Rehabilitation, physical therapy and occupational health

Abstract

Background

Chronic musculoskeletal pain affects more than 20% of the population, and the prevalence is increasing, causing suffering, loss of quality of life, disability, and an enormous expenditure on healthcare resources. The most common location for chronic pain is the spine. Many of the treatments used are mainly passive (pharmacological and invasive) and poor outcomes. The treatments currently applied in the public health system do not comply with the recommendations of the main clinical practice guidelines, which suggest the use of educational measures and physical exercise as the first-line treatment. A protocol based on active coping strategies is described, which will be evaluated through a clinical trial and which could facilitate the transfer of the recommendations of the clinical practice guidelines to a primary care setting.

Methods

Randomised and multicentre clinical trials, which will be carried out in 10 Primary Care centres. The trial will compare the effect of a Pain Neuroscience Education program (six sessions, 10 h) and group physical exercise (18 sessions program carried out in six weeks, 18 h), with usual care physiotherapy treatment. Group physical exercise incorporates dual tasks, gaming, and reinforcement of contents of the educational program. The aim is to assess the effect of the intervention on quality of life, as well as on pain, disability, catastrophism, kinesiophobia, central sensitisation, and drug use. The outcome variables will be measured at the beginning of the intervention, after the intervention (week 11), at six months, and a year.

Discussion

Therapeutic interventions based on active coping strategies are essential for the treatment of chronic pain and the sustainability of the Public Health System. Demonstrating whether group interventions have an effect size is essential for optimising resources in such a prevalent problem.

Trial registration

NCT03654235 “Retrospectively registered” 31 August 2018.

Keywords

Chronic pain Chronic spinal pain Pain neuroscience education Physical exercise Treatment protocol Primary care 

Abbreviations

CMP

Chronic musculoskeletal pain

CS

Central sensitisation

CSP

Chronic spinal pain

PC

Primary care

PE

Physical exercise

PNE

Pain neuroscience education

RCT

Randomised clinical trial

Background

Chronic musculoskeletal pain (CMP) affects about 20% of the population in western countries [1, 2, 3], causing suffering, disability, and a significant loss of quality of life in patients affected by it [3, 4]. It also has a great economic impact related to lost working hours and consumption of health resources [2, 5]. In Primary Care (PC), CMP is one of the most common reasons for consultation, being chronic spinal pain (CSP) the most frequent, and with a growing prevalence [6, 7].

PC has not been giving a satisfactory response to the needs of these patients. General practitioners working in PC devote much of their regular workday to seeing patients with CSP, without being quite certain about what the best therapeutic option is in these cases (Pharmacological and non-pharmacological) [8]. The possibilities for referral are multiple, with no certainty that one option is better than the other such as referral to PC physiotherapy, or referral to different specialised care units (traumatology, rheumatology, neurosurgery, the pain care unit, etc.). Even so, the majority of treatments administered to these patients are focused on the treatment of structures that are considered pain generators (muscles, joints, and stenosis), and in blocking the nociceptive pathways, in both cases with poor results [9]. Therefore, a new therapeutic approach is necessary for the treatment of these patients, and in this sense, advances in neuroscience that have occurred in the past years allow us to know that in CSP, central pain processing mechanisms are involved in the maintenance and perpetuation of the painful experience [10, 11].

The clinical characteristics of Central Sensitisation (CS) presented by the majority of these patients have been meticulously detailed [10, 12, 13]. In addition, structural changes have been reported at the cerebral level, with decreased density and volume of grey matter in prefrontal and dorsolateral cortex, thalamus, brainstem, and somatosensory cortex [14, 15, 16], as well as an increase in grey matter volume in the right hippocampus and parahippocampal gyrus [17]. These changes that appear when pain is perpetuated [18], seem to be involved in the dysfunction of the descending inhibitory pathways [10, 19], motor control alterations [20, 21], and the emergence of neural phenomena of long-term potentiation [22] that these patients present. In addition, it is known that patients with CS present kinesiophobia [23], fear-avoidance behaviours [24], disability [2, 25], and high catastrophism levels [26]. Based on this new knowledge, therapeutic approaches are required to reverse or improve the changes described, and in this sense, the most recent clinical practice guidelines recommend patient education and physical exercise in CSP as the first line of action [27, 28, 29, 30, 31].

Therefore, a therapeutic approach is necessary to improve functionality, as well as tools to reverse the structural changes that present in some cerebral areas in patients with CSP and CS. Within the educational approach recommended by the guidelines, pain neuroscience education (PNE) as a health education strategy allows changing cognitions by modifying erroneous beliefs and reduces catastrophism, kinesiophobia, and fear-avoidance behaviours [32].

It has been verified that PNE interventions improve their outcomes if they are combined with a physical exercise (PE) directed program [33]. PE is a first-line recommendation in clinical practice guidelines [27, 28, 29, 30, 31], and in this sense, aerobic PE has proven to be a great ally in the treatment of CSP [34, 35].

It is also known that certain exercises facilitate neurogenesis, produce neuroplastic changes at the cerebral level [36, 37, 38, 39] and activate descending pain inhibitory pathways [40]. In addition, PE improves the functional status of these patients by improving motor control, achieving reduced disability. Therefore, a therapeutic approach based on PNE and a PE directed program, could be a useful tool to improve the quality of life, disability, and to achieve a decrease in perceived pain intensity. With this model that combines PNE and PE, several clinical trials and reviews have been carried out with hopeful outcomes [32, 41, 42, 43], but there is great variability in terms of the time dedicated to educational intervention, therapeutic PE program, and the way to perform this exercise program. Most studies on PNE and PE have been carried out in Anglo–Saxon and northern European countries. Taking into account that psychosocial aspects are important in the chronification of pain, and since distinct cultural environments may have a different influence on these psychosocial aspects [44], it is necessary to develop a protocol adapted to our environment (Spain and similar cultures of southern Europe), and conduct a clinical trial to assess the intervention effect. Trials of this kind have not been made yet in PC in our country.

For the reasons shown, a program has been designed based on active coping strategies that include PNE and PE, and that program has been adapted to our healthcare context of PC. The protocol proposed for the evaluation would allow transferring the clinical practice guidelines recommendations to the field of PC, since it has been detected that the clinicians in PC do not have a clear certainty on how to educate CSP patients, and what the best type of PE that can be prescribed. The designed program, which was born and developed in the National Health Service (SNS), in the Castilla y León division (SACYL), aims to optimise the available resources in PC and in order to have a greater reach, we have opted in its design a group intervention which will be described later on. Group interventions have proven to have high therapeutic potential [45, 46, 47], and do not exclude that, at the individual level, each patient with CSP can receive specific instructions. In the second part of the program, playful (gamification) and double task components are added to the PE program, aimed at activating new neural circuits which promote neurogenesis and neuroplasticity. In addition, the proposed therapeutic approach encourages the acquisition of healthy lifestyles that can have a beneficial effect on comorbidities, present or potential, in CSP patients (Obesity, HTA, type 2 diabetes, risk of fragility fractures, etc.).

The proposed treatment aims to change cognition and erroneous beliefs in patients with CSP, as well as improve functionality and physical condition. The main objective of the study is to improve the quality of life of patients with CSP. As secondary objectives, the aim is to reduce the levels of catastrophism, kinesiophobia, central sensitisation, disability, and pain intensity. It is also intended to register if the proposed approach decreases the drug consumption and the frequency of the health services for CSP patients. If the results of the intervention are favourable, it is intended, in a second phase of the study, to check for structural and functional changes in brain structures of CSP patients, by using Functional Magnetic Resonance imaging (fMRI) and Diffusion Magnetic Resonance imaging (dMRI).

Therefore, it is proposed to evaluate the effectiveness and cost-effectiveness of a programme based on active coping strategies that include PNE and PE by means of a randomised clinical trial compared to usual care in PC physiotherapy. The protocol outlined describes the characteristics of an educational and physical exercise program, which could be implemented in PC centres of the Spanish National Health Service in case the results are favourable.

Methods and study design

The clinical trial has been registered (Clinicaltrials.gov NCT03654235) and has received approval from the Ethics Committee of Clinical Investigation (CEIC) of the East Valladolid health area (CASVE-NM _ 16–252) and of the CEIC of the West Valladolid health area (CEIC: 26/17).

This study protocol describes the design of a multicentric randomised clinical trial (RCT) of parallel groups (ratio 1:1) to be carried out in 10 health centres within the Public Health network areas of East Valladolid and West Valladolid, belonging to the public health service of Castilla y León (Spain). The study protocol conforms with the standard protocol items: Recommendations for Interventional Trials (SPIRIT) [48] while the RCT conforms to the Consolidated Standards of Reporting Trials (CONSORT) [49].

Patients will be recruited from family medicine consultations and will be referred to PC physiotherapy units. For patient recruitment, the questionnaire contained in Annex I are used. The RCT flow diagram is shown in Annex I.

Inclusion criteria

The patients will be recruited from the PC medical consultations in accordance with the following inclusion criteria:
  • Patients of both sexes between 18 and 70 years old.

  • Non-specific back pain of at least six months (The presence of pain in other regions, in addition to the back, will not be grounds for exclusion)

  • Agree to participate in the study and sign informed consent.

Exclusion criteria

  • Oncological pain.

  • Spine fracture or surgical intervention in the previous year.

  • The neurological cognitive alteration that prevents understanding the contents of the PNE program (In case of doubt, assessment with the Minimental test will be conducted [50]. The minimum score is 25 [51])

  • Physical performance deficit that prevents the execution of the planned PE program (Minimum requirement: execution in normal time (10″) of the Timed Up and Go test).

  • Pregnancy.

  • Cauda equina syndrome.

  • Patients presenting other clinical conditions that may aggravate chronic spinal pain (chronic fatigue syndrome, fibromyalgia and complex regional pain syndrome).

  • Patients with associated pathologies that make it impossible to perform a physical exercise program (myopathies, neurological diseases, etc., with significant impairment of functionality)

  • Patients on treatment with alternative therapies.

Recruitment method

Patients attending family medicine and physiotherapy consultations at the participating centres that meet the inclusion criteria will be invited to participate in the RCT. Physicians and physiotherapists involved in the recruitment process will receive a clinical session to ensure the selection process is carried out in compliance with the inclusion criteria, and that the participants do not meet the exclusion criteria. Patients will receive oral information and a written document (Patient information sheet). If the patient is interested in participating in the study, after signing the informed consent, he will be cited to be evaluated by an external evaluator who will perform the initial assessment. In the same act of the informed consent, the patient will receive a revocation sheet in case they decide to leave the study at any time. After the initial evaluation, participants will be randomly assigned to one of the two study groups (experimental or control).

Randomisation

After the initial evaluation, each patient will be assigned an alphanumeric code. The alphabetic part of the code will correspond to the participant’s health centre, while the numerical part is allocated by correlative numbers. To perform the randomisation procedure, the Health Technician of the health area of East Valladolid will receive a list of the alphanumeric codes of the participants and make a random allocation using the SPSS statistical package.

Blinding

All evaluations will be performed by evaluators who do not know the group to which the patient has been assigned. An independent biostatistician will perform the statistical analysis without knowing the treatment carried out by each group. It will not be possible to blind the intervention performed or the physiotherapists who perform it, but physiotherapists who perform the intervention do not participate in the patient evaluation process.

Interventions

A brief descrption of trial's arms are shown in Table 1. The intervention of the experimental group

Patients assigned to the experimental group will perform a PNE program consisting of six sessions (10 h) and 18 sessions of therapeutic PE to be performed in six weeks (18 h), with a frequency of three sessions per week. The program will be carried out according to the order shown in Fig. 1.
Fig. 1

Temporal distribution of program sessions (experimental group)

Table 1

A brief description of the trial’s arms

Arms

Assigned Interventions

Experimental: PNE and PE program

Pain neuroscience education (Health education)

Physical exercise program

Health Education

Six pain neuroscience education sessions (10 h) and delivery of printed reinforcement material.

Physical exercise

Group physical exercise program (18 sessions: three sessions/week) led by a physiotherapist. It includes exercises to improve strength, coordination, balance, and aerobic capacity. Work with double tasks, recreational activities to overcome kinesiophobia and activities to do at home are used in the program.

Active Comparator: Usual care in Primary Care Physiotherapy

Usual care in Primary Care Physiotherapy Units

Usual care in Primary Care Physiotherapy Units

Treatment supported by the primary care physiotherapy protocol in the health service of Castilla y León that was in force at the time of the intervention. Patients receive 15 sessions of analgesic electrotherapy, thermotherapy and standardised physical exercise.

PNE is a health education intervention that aims to provide up-to-date information on neuroscience advances in the field of chronic pain. For this purpose, a group educational program has been designed, the contents of which appear in the Additional file 1. Pedagogical resources that facilitate the learning process will be used to enhance knowledge transfer. The times in which patients are merely information receivers, and the times in which they actively participate, will be adequately dosed. Care has been taken with the graphic material that will accompany the presentations, and infographics have been created to facilitate the process. All sessions will use explanatory and motivational videos. The educational intervention will be essential to raise awareness of the need for lifestyle changes and ensure that participants arrive at the second part of the program, which will start the PE, in an “Action Stage”, following the transtheoretical model of Prochaska and Diclemente [52, 53].

PE is carried out in group form, although this will not be an impediment for each participant during the session to receive individualised advice from the physiotherapist. During the sessions, references to the theoretical contents that have been learned in the first part of the program will be made repeatedly. It is essential that patients understand what they do and why they do it. Since patients with CSP have an alteration in their pain inhibitory system [54], the dosage of the scheduled exercise requires taking certain precautions and adapting the exercise dose to the patient’s functional status [34]. The inhibitory system dysfunction may cause an increase in pain during the first PE sessions. Aware of this fact, it will be necessary to be prepared so that this transient increase in symptoms is not lived with alarmism. The appearance of pain during exercise, as long as we move at appropriate levels of intensity, will never be a reason to stop the activity [55, 56]. At all times, during the PE sessions, the increase in functionality is sought as a reference. This aspect will be previously reinforced in the education sessions.

PE sessions will have a basic structure that complies with the recommendations of the American College of Sports Medicine (ACSM) [57], with a warm-up phase, the main part, and a cooling-down part, as can be seen in Fig. 2. This distribution also allows incorporating dual tasks, games, and tasks aimed at stimulating social interaction.
Fig. 2

Structure of sessions (experimental group)

To perform the exercise, a series of guidelines and progressions will be followed, which are described in the Additional file 1. The physiotherapists that will apply this PE protocol in the participating PC centres, will receive training on how to perform the program, what to say to patients, and how to resolve conflicts that may arise during the development of the program.

Control group intervention

The control group will receive the standard care treatment carried out in the PC physiotherapy units that is supported by the current physiotherapy protocols in primary care of Castilla y León [58]. The treatment consists of 15 sessions of thermotherapy and analgesic electrotherapy in the area of pain, and the guidelines for the exercises recommended by the SERMEF (Spanish Society of Physic Medicine and Rehabilitation) [59].

Sample size calculation

A total of 63 individuals by each group of treatment will allow detecting, in numerical variables, differences between pairs of group mean in a magnitude corresponding to 50% of the standard deviation (an effect size of 50%) with a probability of 80%, keeping the type I error at a 5% level. By taking into account an attrition rate of 25%, it would be necessary to include 78 individuals in each group. The calculation has been done using G*Power 3.1.

Statistical analysis

Numerical variables will be summarised with means and standard deviations and categorical ones with percentages. Those numerical variables showing a distribution very far from the normal one will be transformed for getting resulting distributions close to the normal one, or in the opposite case, they will be summarised by using percentiles. For the graphical representation of the numerical variables’ distribution in each treatment group, we will use box and whisker plots. For representing categorical variables, pie charts will be used. In order to test the equality of means for numerical variables, we will apply the Student’s t, if the corresponding distributions are not far from the normal one. In the opposite scenario, we will calculate the Wilcoxon–Mann–Whitney statistics. For testing the association between qualitative variables, we will use Chi-squared statistics, if it is allowed by the observed frequencies in the associated joint distribution. On the contrary, we will re-categorise these variables for reducing them to dichotomous ones, if necessary, and will apply the Fisher exact test. As a function of the observed response to the treatment in numerical variables or the observed change in them, we will build several definitions of success/failure for the result of treatment in individuals. We will fit logistic regression models for predicting the success of the treatment by using the previously mentioned definitions. In these models, those variables which show a statistically significant relationship with the corresponding response variables in the univariate analysis and the variable selection procedures will be included. These models will provide us, as a by-product, odds ratio values for estimating the comparative risk of success associated with each explanatory variable corrected by the presence of the other variables included in them. We will obtain estimates for the sensitivity/specificity of predictive rules derived from these models. It will be considered as statistically significant p-values lower than 0.05. Data analysis will be carried by using the R statistical software.

Outcomes variables

All variables will be measured before the intervention, after the intervention (week 11), at six months, and a year. Flowchart of the study can be seen in Fig. 3.
Fig. 3

Flowchart of the study

Initial personal and sociodemographic variables

  • Age (in years)

  • Sex

  • Health Centre

  • Level of studies (no studies, basic education, secondary school, university studies)

  • Employment situation (student, active, active in temporary disability, unemployed, domestic occupation)

  • Marital status (single, widowed, couple, separated or divorced)

  • Weight (kg), height, body mass Index (weight [kg]/height [m2]), and abdominal perimeter.

  • Time since the onset of symptoms (months)

  • Pain areas (McGill pain maps) [60]

Main outcomes variables

The primary outcome measure will be the difference between groups in health-related quality of life changes at different times. The Spanish version of the health Survey SF-36 V2 will be used [61, 62]. SF-36 is a 36-item scale built to assess health status and quality of life. It produces a profile of eight levels of functional health and wellness scores, as well as a summary of psychometric-based mental and physical health. Each scale transforms directly into a scale of 0–100. Higher scores indicate a better quality of life in general.

Secondary outcome variable

  • Pain intensity: VAS scale (0–100 mm) [63]. Participants will be shown a horizontal line 100 mm long which ranges from 0 (“no pain”) to 100 (“the worst pain imaginable”). The participants will draw a mark on the line at a point which best represents the pain they are experiencing at the moment it is being measured. Higher scores indicate a higher pain level.

  • Pressure pain threshold (kg/cm2). To measure this the protocol described in the study by Neziri et al. [64] will be used, measuring four points using the procedure described by Fisher [65]. The reference points will be the middle point in a horizontal line drawn between the posterior border of the acromion and the spinal process of the seventh cervical vertebra, bilaterally, and the middle point of a horizontal line drawn between the highest part of the superior border of the iliac crest and the spinal process at the same height, also bilaterally. This protocol has been validated in an asymptomatic population and can be useful when evaluating patients with central sensitisation processes [64, 66]. A Fisher digital algometer of the Wagner brand will be used. Digital algometry also presents good interobserver reliability [67, 68]. The threshold will be determined when the sensation of pressure turns to a painful sensation for the patient. Two measurements will be made at each point, increasing the pressure to a rate of 1 kg/cm2 per second. The average of two consecutive measurements shall be determined [66].

  • Catastrophising. The Spanish version of the Pain Catastrophising scale (PCS) will be used [69]. This is a brief 13-item questionnaire that assesses pain-related behaviours and cognition. Scores range from 0 to 52, with higher scores indicating a higher level of catastrophising [70].

  • Kinesiophobia: The Spanish version of the Tampa Scale of Kinesiophobia (TSK-11) will be used. This is a self-reported questionnaire containing 11 items designed to assess a patient’s fear of moving and re-injury. Scores range between 11 and 44 points, with a higher score indicating higher levels of kinesiophobia.

  • Central Sensitisation: The Spanish version of the Central Sensitisation Inventory will be used [72]. This is a self-reported questionnaire used to detect the presence of central sensitisation. It contains 25 items registering the frequency of each symptom on a Likert scale from 0 (never) to 4 (always), the highest score being 100 points. Higher scores are associated with higher levels of central sensitisation. The questionnaire provides reliable and valid data that quantify the severity of various symptoms of central sensitisation [73].

  • Disability: The Roland–Morris disability questionnaire will be used [74]. This is a self-reported disability questionnaire consisting of 24 questions specifically related to physical functions that may be affected by back pain. Scores range from 0 to 24 points, where a higher score indicates a higher level of disability.

  • Body mass index: Changes in body mass index will be assessed. Weight values measured in kilograms and height measured in meters will be combined to report the BMI in kg/m2.

  • Medication intake: The medication intake by types of drugs will be registered by means of a survey. The results will be expressed in weekly doses by the type of drug taken.

  • Health Services visits: Visits to the family doctor, emergency services, and medical specialists will be registered during the follow-up period.

  • Satisfaction with the treatment received: The Spanish version of the Client Satisfaction Questionnaire (CSQ-8) will be used [75]. The CSQ-8 is a self-report tool used to assess satisfaction with health services.

Discussion

This study will provide new information on the effectiveness of a new program based on PNE and PE in the Spanish National Health Services, in the region of Castilla y León. The results of this study may be useful in future planning of the management of chronic pain in health services and provide the basis for future cost-effective studies, as well as optimising the available resources for more effective management of CSP.

Using a clinical trial to assess a health service is not something new. However, changes in health services affect a great number of people and require modifying structures and cultures of service. Therefore, it is mandatory to gather the information available with solid and robust evidence and test it in its context prior to modifying the services.

Previous studies suggest that management based on PNE and PE improves the quality of life of patients with CSP. None of these studies has been conducted using group work in a primary healthcare environment inside the Public Health System. The sample size used in the study may allow reaching solid conclusions about the effectiveness of the proposed treatment. Study results with an effect size superior to 0.8 (Cohen’s d) in the different variables measured could be the starting point to change the therapeutic management used in the first level of care for patients suffering from chronic musculoskeletal pain. Group work may also allow optimisation of the available resources and also allow the program to reach more patients.

Initially, our study does not include tools that allow us to quantify if the intervention produces changes on a neuroplastic and structural level and changes related to the connectivity between different brain areas. However, if the clinical results regarding improvement in the quality of life, function, and pain reduction are positive, a second study with dMRI and resting state fMRI is planned to assess whether changes occur at the brain level.

There is controversy as to whether individual or group treatments are best. In our field of care, due to the high pressure of care and in order to optimise resources, we have opted for group treatment. We take advantage of the fact that the group strategy itself is a very powerful therapeutic tool, as it extols values such as group feelings, stimulates, improves self-esteem, and generates more adherence than the individual strategy [45, 46, 47]. However, this does not prevent each participant from receiving individualised guidelines for the therapeutic program.

Notes

Acknowledgements

Our thanks to all the team at the primary care centres where the trial will take place (Pilarica, Barrio España, Tórtola, Parquesol, Arturo Eyries, Tudela de Duero, Laguna de Duero, Medina del Campo, Iscar, and Olmedo).

Our special thanks to the physiotherapists who will collaborate in the trial development (Calleja-Camarero R, Simarro-Martín A, Diaz-Nieto N, García-Rodríguez N, Gómez -Pérez Y, Llamas-Morejón JC, Larren-Fraile JC, Sánchez C, Martín-Molpeceres B, Esteban-Redondo O and Rivero-Andrés I)

Authors’ contributions

MG and FM designed the study and wrote the report. EL, AC and CC provided methodological advice for the design of the study. AM made the designs of the statistical analysis. All authors provided critical revisions to the report and final approval of the manuscript.

Funding

The clinical trial that has allowed the development of the present protocol has been made possible thanks to the funding received from the Regional Health Management of Castilla y León and the Professional College of Physiotherapists of Castilla y León.

AM have been partially supported by the Spanish Ministry of Economy and Competitiveness, grant MTM2017–86061-C2–1-P, and by Education Department of Castilla and León Government and FEDER, grant VA005P17 and VA002G18.

The funding bodies were not involved in the in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Ethics approval and consent to participate

This study has been approved by the Ethics and Clinical Research Committee in the East Valladolid health area (CASVE-NM_16–252), and by the Ethics and Clinical Investigation Committee in the West Valladolid health area (CEIC:26/17), and shall be carried out in accordance with the Declaration of Helsinki. The informed consent material is available in Spanish with the approved protocol. The informed consent obtained was written. Adverse effects from the treatment are not expected to occur, but if they do, all patients will be covered by the Public Health System.

Consent for publication

Written consent was received from all participants to publicly share the results of the study.

Competing interests

The authors declare that they have no competing interests.

Supplementary material

12891_2019_2889_MOESM1_ESM.docx (47 kb)
Additional file 1: PNE and PE Program Description.

References

  1. 1.
    Langley PC. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin [Internet]. 2011 Feb 11 [cited 2016 Mar 25];27(2):463–480. Available from: http://www.tandfonline.com/doi/full/10.1185/03007995.2010.542136
  2. 2.
    Breivik H, Eisenberg E, O’Brien T. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health [Internet]. 2013;13(1):1229. Available from: http://www.biomedcentral.com/1471-2458/13/1229
  3. 3.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) [Internet]. 2018 Nov 10 [cited 2019 Apr 12];392(10159):1789–1858. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30496104
  4. 4.
    Langley P, Müller-Schwefe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization. J Med Econ [Internet]. 2010 Sep 3 [cited 2016 Mar 25];13(3):571–81. Available from: http://www.tandfonline.com/doi/full/10.3111/13696998.2010.516709.PubMedCrossRefGoogle Scholar
  5. 5.
    Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain [Internet] 2012;13(8):715–724. Available from:  https://doi.org/10.1016/j.jpain.2012.03.009 PubMedCrossRefGoogle Scholar
  6. 6.
    Jordan KP, Kadam UT, Hayward R, Porcheret M, Young C, Croft P. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord [Internet]. 2010 Dec 2 [cited 2019 Apr 8];11(1):144. Available from: https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-11-144
  7. 7.
    Hurwitz EL, Randhawa K, Yu H, Côté P, Haldeman S. The Global Spine Care Initiative: a summary of the global burden of low back and neck pain studies. Eur Spine J [Internet]. 2018; Available from: http://www.ncbi.nlm.nih.gov/pubmed/29480409.
  8. 8.
    Nijs J, Meeus M, Oosterwijck J Van, Roussel N, Kooning M De, Ickmans K, et al. Treatment of central sensitization in patients with ‘ unexplained ’ chronic pain : what options do we have? Expert Opin Pharmacother [Internet]. 2011 May 22 [cited 2019 May 28];12(7):1–12. Available from: http://www.tandfonline.com/doi/full/10.1517/14656566.2011.547475
  9. 9.
    Jonas WB, Crawford C, Colloca L, Kriston L, Linde K, Moseley B, et al. Are invasive procedures effective for chronic pain? A systematic review. Pain Med [Internet]. 2018 Sep 10 [cited 2018 Dec 14]; Available from: https://academic.oup.com/painmedicine/advance-article-abstract/doi/10.1093/pm/pny154/5094687
  10. 10.
    Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain [Internet]. 2011;152(SUPPL.3):S2–15. Available from:  https://doi.org/10.1016/j.pain.2010.09.030 CrossRefGoogle Scholar
  11. 11.
    Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Woolf CJ, Bennett GJ, Doherty M, Dubner R, Kidd B, Koltzenburg M, et al. Towards a mechanism-based classification of pain? Pain. 1998;77(3):227–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Nijs J, Van Houdenhove B, Oostendorp RAB. Recognition of central sensitization in patients with musculoskeletal pain: Application of pain neurophysiology in manual therapy practice. Man Ther [Internet]. 2010 Apr [cited 2016 Mar 24];15(2):135–141. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1356689X09001921
  14. 14.
    Apkarian A V. Chronic back pain is associated with decreased prefrontal and thalamic gray matter Ddensity. J Neurosci [Internet]. 2004 Nov 17 [cited 2016 Mar 24];24(46):10410–10415. Available from: http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.2541-04.2004
  15. 15.
    Wood PB. Variations in brain gray matter associated with chronic pain. Curr Rheumatol Rep [Internet]. 2010 Dec 21 [cited 2016 Mar 24];12(6):462–469. Available from: http://link.springer.com/10.1007/s11926-010-0129-7
  16. 16.
    May A. Chronic pain may change the structure of the brain. Pain. 2008;137(1):7–15.PubMedCrossRefGoogle Scholar
  17. 17.
    Smallwood RF, Laird AR, Ramage AE, Parkinson AL, Lewis J, Clauw DJ, et al. Critical review. structural brain anomalies and chronic pain: A quantitative meta-analysis of gray matter volume. J Pain [Internet]. 2013 [cited 2019 Jan 12];14(7):663–675. Available from: www.jpain.organdwww.sciencedirect.com PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A. Brain gray matter decrease in chronic pain ss the consequence and not the cause of pain. J Neurosci [Internet]. 2009 Nov 4 [cited 2016 Mar 24];29(44):13746–13750. Available from: http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.3687-09.2009
  19. 19.
    Daenen L, Nijs J, Roussel N, Wouters K, Van Loo M, Cras P. Dysfunctional pain inhibition in patients with chronic whiplash-associated disorders: an experimental study. Clin Rheumatol [Internet]. 2013 Jan 16 [cited 2016 Mar 24];32(1):23–31. Available from: http://link.springer.com/10.1007/s10067-012-2085-2 PubMedCrossRefGoogle Scholar
  20. 20.
    Hodges PW, Tucker K. Moving differently in pain: a new theory to explain the adaptation to pain. Pain [Internet] 2011;152(SUPPL.3):S90–S98. Available from:  https://doi.org/10.1016/j.pain.2010.10.020 PubMedCrossRefGoogle Scholar
  21. 21.
    Tsao H, Galea MP, Hodges PW. Reorganization of the motor cortex is associated with postural control deficits in recurrent low back pain. Brain [Internet]. 2008 Aug 1 [cited 2018 Dec 10];131(8):2161–2171. Available from: https://academic.oup.com/brain/article-lookup/doi/10.1093/brain/awn154 PubMedCrossRefGoogle Scholar
  22. 22.
    Salter MW. The neurobiology of central sensitization. J Musculoskelet Pain. 2002;10(1–2):23–33.CrossRefGoogle Scholar
  23. 23.
    Fletcher C, Bradnam L, Barr C. The relationship between knowledge of pain neurophysiology and fear avoidance in people with chronic pain: A point in time, observational study. Physiother Theory Pract. 2016;32(4).PubMedCrossRefGoogle Scholar
  24. 24.
    Leeuw M, Goossens MEJB, Linton SJ, Crombez G, Boersma K, Vlaeyen JWS. The fear-avoidance model of musculoskeletal pain: Current state of scientific evidence. J Behav Med [Internet]. 2007 Jan 31 [cited 2016 Mar 24];30(1):77–94. Available from: http://link.springer.com/10.1007/s10865-006-9085-0 PubMedCrossRefGoogle Scholar
  25. 25.
    Cieza A, Stucki G, Weigl M, Kullmann L, Stoll T, Kamen L, et al. ICF Core Sets for chronic widespread pain. J Rehabil Med [Internet]. 2004 Aug 1 [cited 2017 Feb 19];36(0):63–68. Available from: http://journalsonline.tandf.co.uk/Index/10.1080/16501960410016046 CrossRefGoogle Scholar
  26. 26.
    Nijs J, Meeus M, Cagnie B, Roussel NA, Dolphens M, Van Oosterwijck J, et al. A modern neuroscience approach to chronic spinal pain: Combining pain neuroscience education with cognition-targeted motor control training. Phys Ther [Internet]. 2014 May 1 [cited 2016 Mar 20];94(5):730–738. Available from: http://ptjournal.apta.org/cgi/doi/10.2522/ptj.20130258 PubMedCrossRefGoogle Scholar
  27. 27.
    Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet [Internet]. 2018 Jun [cited 2018 Mar 26];391(10137):2368–83. Available from: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)30489-6.pdf.
  28. 28.
    Wong JJ, Côté P, Sutton DA, Randhawa K, Yu H, Varatharajan S, et al. Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J Pain [Internet]. 2017 Feb 1 [cited 2018 Nov 29];21(2):201–216. Available from: http://doi.wiley.com/10.1002/ejp.931 PubMedCrossRefGoogle Scholar
  29. 29.
    Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, Andersen MØMM, et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J [Internet]. 2018;27(1):60–75 Available from: http://link.springer.com/10.1007/s00586-017-5099-2.CrossRefGoogle Scholar
  30. 30.
    Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the american college of physicians. Ann Intern Med [Internet]. 2017 Apr 4 [cited 2018 Nov 29];166(7):514. Available from: http://annals.org/article.aspx?doi=10.7326/M16-2367 PubMedCrossRefGoogle Scholar
  31. 31.
    Babatunde OO, Jordan JL, Van der Windt DA, Hill JC, Foster NE, Protheroe J. Effective treatment options for musculoskeletal pain in primary care: A systematic overview of current evidence. Fleckenstein J, editor. PLoS One [Internet]. 2017 Jun 22;12(6):e0178621. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28640822%0A  https://doi.org/10.1371/journal.pone.0178621 PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Louw A, Diener I, Butler DS, Puentedura EJ. The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil [Internet]. 2011 Dec [cited 2016 Feb 26];92(12):2041–2056. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0003999311006708 PubMedCrossRefGoogle Scholar
  33. 33.
    Geneen LJ, Martin DJ, Adams N, Clarke C, Dunbar M, Jones D, et al. Effects of education to facilitate knowledge about chronic pain for adults: a systematic review with meta-analysis. Syst Rev [Internet]. 2015;4(1):132. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4591560&tool=pmcentrez&rendertype=abstract
  34. 34.
    Daenen L, Varkey E, Kellmann M, Nijs J. Exercise, not to exercise, or how to exercise in patients with chronic pain? Applying science to practice. Clin J Pain [Internet]. 2015 Feb [cited 2016 mar 20];31(2):108–114. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24662498.PubMedCrossRefGoogle Scholar
  35. 35.
    Geneen L, Smith B, Clarke C, Martin D, Colvin LA, Moore RA. Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews. Cochrane Database Syst Rev [Internet]. 2017;(2017 Issue 1):4. Available from: http://doi.wiley.com/10.1002/14651858.CD011279
  36. 36.
    Snodgrass SJ, Heneghan NR, Tsao H, Stanwell PT, Rivett DA, Van Vliet PM. Recognising neuroplasticity in musculoskeletal rehabilitation: a basis for greater collaboration between musculoskeletal and neurological physiotherapists. Man Ther [Internet] 2014;19(6):614–617. Available from:  https://doi.org/10.1016/j.math.2014.01.006 PubMedCrossRefGoogle Scholar
  37. 37.
    Juul T, Søgaard K, Davis AM, Roos EM. Psychometric properties of the Neck OutcOme Score (NOOS), Neck Disability Index (NDI) and Short form-36 (SF-36) in longitudinal assessment of patients with neck pain. J Rehabil Med [Internet]. 2016;36. Available from:  https://doi.org/10.1016/j.jclinepi.2016.03.015 PubMedCrossRefGoogle Scholar
  38. 38.
    Rogge A-K, Röder B, Zech A, Hötting K. Exercise-induced neuroplasticity: Balance training increases cortical thickness in visual and vestibular cortical regions. Neuroimage [Internet]. 2018;179:471–479. Available from: https://linkinghub.elsevier.com/retrieve/pii/S105381191830572X PubMedCrossRefGoogle Scholar
  39. 39.
    Amir S, Batouli H, Saba V, Amir S. At least eighty percent of brain grey matter is modifiable by physical activity: a review study medical imaging view project electromagnetic waves view project at least eighty percent of brain grey matter is modifiable by physical activity: a review study. Behav Brain Res. 2017;332:204–17.CrossRefGoogle Scholar
  40. 40.
    Ray CA, Carter JR. Central modulation of exercise-induced muscle pain in humans. J Physiol [Internet]. 2007 Nov 15 [cited 2016 Mar 25];585(1):287–294. Available from: http://doi.wiley.com/10.1113/jphysiol.2007.140509 PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Louw A, Zimney K, Puentedura EJ, Diener I. The efficacy of pain neuroscience education on musculoskeletal pain: a systematic review of the literature. Physiother theory Pract [Internet]. 2016;3985(September):1–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27351541.
  42. 42.
    Malfliet A, Kregel J, Coppieters I, Pauw R De, Meeus M, Roussel N, et al. Effect of pain neuroscience education combined with cognition-targeted Motor Control Training on Chronic Spinal Pain: A Randomized Clinical Trial. JAMA Neurol [Internet]. 2018; Available from: http://archneur.jamanetwork.com/article.aspx?doi=10.1001/jamaneurol.2018.0492
  43. 43.
    Marques ES, Meziat Filho NA de M, Ferreira P dos S, Andrade FG de, Ramsay EM, Amaral Corrêa L, et al. Group pain neuroscience education combined with supervised exercises reduces pain and improves function of Brazilian women with central sensitisation and a low level of education: a single-subject study. Eur J Physiother [Internet]. 2019;21(4):224–32. Available from: https://www.tandfonline.com/doi/abs/10.1080/21679169.2018.1531922?journalCode=iejp20&.
  44. 44.
    Edwards RR, Sullivan MD, Wasan AD. The role of psychosocial processes in the development and maintenance of chronic pain. J Pain [Internet]. 2016 Sep 1 [cited 2018 Dec 12];17(9):T70–T92. Available from: https://www.sciencedirect.com/science/article/pii/S1526590016000183 PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Burke SM, Carron A V, Eys MA, Ntoumanis N, Estabrooks PA. Group versus individual approach? A meta-analysis of the effectiveness of interventions to promote physical activity. Sport Exerc Psychol Rev [Internet]. 2006 [cited 2018 Dec 17];2:1–13. Available from: http://eprints.bham.ac.uk/426/
  46. 46.
    Yorks DM, Frothingham CA, Schuenke MD. Effects of group fitness classes on stress and quality of life of medical students. J Am Osteopath Assoc [Internet]. 2017 Nov 1 [cited 2018 Dec 17];117(11):e17. Available from: http://jaoa.org/article.aspx?doi=10.7556/jaoa.2017.140
  47. 47.
    Jakobsen MD, Sundstrup E, Brandt M, Jay K, Aagaard P, Andersen LL. Effect of workplace- versus home-based physical exercise on musculoskeletal pain among healthcare workers: a cluster randomized controlled trial. Scand J Work Environ Health [Internet]. 2015 Mar [cited 2018 Dec 17];41(2):153–163. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25596848.CrossRefGoogle Scholar
  48. 48.
    Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med [Internet]. 2013 Feb 5 [cited 2019 mar 29];158(3):200–207. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23295957.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol [Internet]. 2010 Aug 1 [cited 2019 mar 29];63(8):e1–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20346624.
  50. 50.
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res [Internet]. 1975 Nov 1 [cited 2019 Mar 29];12(3):189–198. Available from: https://www.sciencedirect.com/science/article/pii/0022395675900266?via%3Dihub
  51. 51.
    Llamas Velasco S, Llorente Ayuso L, Contador I, Bermejo Pareja F. Versiones en español del Minimental State Examination (MMSE). Cuestiones para su uso en la práctica clínica. Rev Neurol [Internet]. 2015 [cited 2019 Mar 29];61(08):363. Available from: https://www.neurologia.com/articulo/2015107 PubMedCrossRefGoogle Scholar
  52. 52.
    Prochaska JO, DiClemente CC. Transtheoretical therapy: Toward a more integrative model of change. Psychother Theory, Res Pract [Internet]. 1982 [cited 2018 Dec 9];19(3):276–288. Available from: http://doi.apa.org/getdoi.cfm?doi=10.1037/h0088437
  53. 53.
    Prochaska JO. Decision making in the transtheoretical model of behavior change. Med Decis Mak [Internet]. 2008 [cited 2018 Dec 9];28:845–849. Available from: https://sagepub.publicaciones.saludcastillayleon.es/doi/pdf/10.1177/0272989X08327068
  54. 54.
    Nijs J, Kosek E, Oosterwijck J Van, Meeus M, Van Oosterwijck J, Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise? Pain Physician [Internet]. 2012 [cited 2018 Dec 8];15(3 Suppl):205–14. Available from: http://www.painphysicianjournal.com.
  55. 55.
    Smith BE, Hendrick P, Bateman M, Holden S, Littlewood C, Smith TO, et al. Musculoskeletal pain and exercise— challenging existing paradigms and introducing new. Br J Sport Med Mon 2018;(0).Google Scholar
  56. 56.
    Smith BE, Hendrick P, Smith TO, Bateman M, Moffatt F, Rathleff MS, et al. Should exercises be painful in the management of chronic musculoskeletal pain? A systematic review and meta-analysis. Br J Sports Med [Internet]. 2017 Dec 1 [cited 2018 Dec 12];51(23):1679–1687. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28596288.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Thompson PD, Arena R, Riebe D, Pescatello LS, American College of Sports Medicine. ACSM’s New preparticipation health screening recommendations from ACSM’s guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep [Internet]. 2013 [cited 2018 Dec 28];12(4):215–217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23851406.PubMedCrossRefGoogle Scholar
  58. 58.
    Dirección General de Asistencia Sanitaria. Protocolos de Fisioterapia en Atención Primaria [Internet]. Valladolid; 2005. Available from: http://www.saludcastillayleon.es/institucion/es/publicaciones-consejeria/buscador/protocolos-fisioterapia-atencion-primaria
  59. 59.
    SERMEF (Sociedad Española de Medicina Física y Rehabilitación). WEB EJERCICIOS SERMEF – SERMEF [Internet]. [cited 2019 Apr 6]. Available from: https://www.sermef.es/web-ejercicios-sermef/
  60. 60.
    Melzack R. The short-form McGill pain questionnaire. Pain. 1987 Aug;30(2):191–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Vilagut G, Valderas JM, Ferrer M, Garin O, López-García E, Alonso J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental. Med Clin (Barc) [Internet]. 2008 [cited 2018 Jul 6];130(19):726–735. Available from: http://public-files.prbb.org/publicacions/e92966f0-cead-012b-a7a8-000c293b26d5.pdf
  62. 62.
    Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, De la Fuente L. Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36. Med Clin (Barc). 1998;111(11):410–6.Google Scholar
  63. 63.
    Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain. 1985;22(1):1–31.PubMedCrossRefGoogle Scholar
  64. 64.
    Neziri AY, Scaramozzino P, Andersen OK, Dickenson AH, Arendt-Nielsen L, Curatolo M. Reference values of mechanical and thermal pain tests in a pain-free population. Eur J Pain [Internet] 2011;15(4):376–383. Available from:  https://doi.org/10.1016/j.ejpain.2010.08.011 CrossRefGoogle Scholar
  65. 65.
    Fischer AA. Algometry in diagnosis of musculoskeletal pain and evaluation of treatment outcome: An update. J Musculoskelet Pain [Internet]. 1998 Jan 16 [cited 2017 Feb 3];6(1):5–32. Available from: http://www.tandfonline.com/doi/full/10.1300/J094v06n01_02
  66. 66.
    Balaguier R, Madeleine P, Vuillerme N. Is one trial sufficient to obtain excellent pressure pain threshold reliability in the low back of asymptomatic individuals? A test-retest study. PLoS One [Internet]. 2016;11(8):1–16 Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160866.Google Scholar
  67. 67.
    Escobar JCZ, Del Pozo MG, Propin MG. Modificaciones del umbral de dolor en un punto gatillo miofascial tras técnica de energía muscular. Rev la Soc Esp del Dolor. 2010;17(7):313–9.CrossRefGoogle Scholar
  68. 68.
    Park G, Kim CW, Park SB, Kim MJ, Jang SH. Reliability and usefulness of the pressure pain threshold measurement in patients with myofascial pain. Ann Rehabil Med [Internet]. 2011;35(3):412–7 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3309218&tool=pmcentrez&rendertype=abstract.CrossRefGoogle Scholar
  69. 69.
    García Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S. Validación de la versión española de la escala de la catastrofización ante el dolor (Pain Catastrophizing Scale) en la fibromialgia. Med Clin. 2008;131(13):487–92.CrossRefGoogle Scholar
  70. 70.
    Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess [Internet]. 1995 [cited 2019 Apr 6];7(4):524–532. Available from: http://doi.apa.org/getdoi.cfm?doi=10.1037/1040-3590.7.4.524
  71. 71.
    Gómez-Pérez L, López-Martínez AE, Ruiz-Párraga GT. Psychometric properties of the spanish version of the Tampa scale for Kinesiophobia (TSK). J Pain. 2011;12(4):425–35.PubMedCrossRefGoogle Scholar
  72. 72.
    Cuesta-Vargas AI, Roldan-Jimenez C, Neblett R, Gatchel RJ. Cross-cultural adaptation and validity of the Spanish central sensitization inventory. Springerplus [Internet]. 2016 Dec 21 [cited 2016 Oct 22];5(1):1837. Available from: http://springerplus.springeropen.com/articles/10.1186/s40064-016-3515-4
  73. 73.
    Scerbo T, Colasurdo J, Dunn S, Unger J, Nijs J, Cook C. Measurement properties of the central sensitization inventory: A systematic review. Pain Pract [Internet]. 2018 Apr 1 [cited 2019 Apr 6];18(4):544–554. Available from: http://doi.wiley.com/10.1111/papr.12636
  74. 74.
    Kovacs FM, Llobera J, del Real MTG, Abraira V, Gestoso M, Fernández C. Validation of the Spanish version of the Roland–Morris questionnaire. Spine (Phila Pa 1976). 2002;27(5):538–42.CrossRefGoogle Scholar
  75. 75.
    Roberts RE, Atrkisson CC, Mendias RM. Assessing the client satisfaction questionnaire in English and Spanish. Hisp J Behav Sci [Internet]. 1984 Dec 25 [cited 2019 Apr 6];6(4):385–396. Available from: http://journals.sagepub.com/doi/10.1177/07399863840064004
  76. 76.
    Galán-Martín M, Montero-Cuadrado F. Educación en neurociencia del dolor. Una nueva visión. dossier para pacientes. First edit. Junta de Castilla y León, editor. Junta de Castilla y León: Valladolid; 2018. 92 p.Google Scholar
  77. 77.
    Howick J, Moscrop A, Mebius A, Fanshawe TR, Lewith G, Bishop FL, et al. Effects of empathic and positive communication in healthcare consultations: a systematic review and meta-analysis. J R Soc Med [Internet]. 2018 Jul 19 [cited 2019 Apr 15];111(7):240–252. Available from: http://journals.sagepub.com/doi/10.1177/0141076818769477 PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Goicoechea A, Echávarri R. Migraña : una pesadilla cerebral [Internet]. Desclée de Brouwer; 2009 [cited 2017 Jul 8]. 342 p. Available from: https://www.edesclee.com/tematicas/psicologia/migrana-una-pesadilla-cerebral-detail
  79. 79.
    Butler D, Moseley L. Explain pain. 2nd ed. Adelaide: NOI group Publications; 2013. p. 133.Google Scholar
  80. 80.
    Louw A , Puentedura E. Therapeutic neuroscience education : teaching patients about pain : a guide for clinicians. Louisville: International Spine and Pain Institute; 2013. p. 292.Google Scholar
  81. 81.
    Nijs J, Lluch Girbés E, Lundberg M, Malfliet A, Sterling M. Exercise therapy for chronic musculoskeletal pain: Innovation by altering pain memories. Man Ther [Internet]. 2015 Feb 1 [cited 2017 Nov 27];20(1):216–220. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25090974.
  82. 82.
    Booth J, Moseley GL, Schiltenwolf M, Cashin A, Davies M, Hübscher M. Exercise for chronic musculoskeletal pain: A biopsychosocial approach. Musculoskeletal Care [Internet]. 2017 Dec 1 [cited 2017 Dec 16];15(4):413–421. Available from: http://doi.wiley.com/10.1002/msc.1191
  83. 83.
    Cohen S, Janicki-Deverts D, Turner RB, Doyle WJ. Does hugging provide stress-buffering social support? A study of susceptibility to upper respiratory infection and illness. Psychol Sci [Internet]. 2015 Feb [cited 2018 Dec 17];26(2):135–147. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25526910.

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Unit for Active Coping Strategies for Pain in Primary Care, East-Valladolid Primary Care Management, Castilla and Leon Public Health System (Sacyl)ValladolidSpain
  2. 2.Doctoral Program of Research in Health SciencesUniversity of ValladolidValladolidSpain
  3. 3.Department of Physical TherapyUniversity of ValenciaValenciaSpain
  4. 4.“Pain in motion” International Research GroupBrusselsBelgium
  5. 5.Department of Human Physiology and Rehabilitation Sciences, Faculty of PhysiotherapyVrije university BrusselsBrusselsBelgium
  6. 6.Castilla and Leon Regional Centre of Sports Medicine, Castilla and Leon Public Health System (Sacyl)ValladolidSpain
  7. 7.Department of Statistics and Operational Research and IMUVAUniversity of ValladolidValladolidSpain
  8. 8.Department of Physiotherapy, Faculty of Heath SciencesUniversity of MalagaMálagaSpain
  9. 9.Institute of Biomedical Research in Malaga. IBIMAMálagaSpain
  10. 10.School of Clinical Science, Faculty of Health ScienceQueensland University TechnologyBrisbaneAustralia

Personalised recommendations